This is a preview of subscription content, log in via an institution to check access.
References
Dollery, C. T., Paterson, J. W., Conolly, M. E.: Clinical pharmacology of β-receptor blocking drugs. Clin. Pharm. Therap.10, 765 (1969).
Frohlich, E. D., Tarazi, R. C., Dustan, H. P., Page, I. H.: The paradox of β-adrenergic blockade in hypertension. Circulation37, 417 (1968).
Gilmore, E., Weil, J., Chidsey, C.: Treatment of essential hypertension with a new vasodilator in combination with β-adrenergic blockade. New Engl. J. Med.282, 521 (1970).
Lund-Johansen, P.: Hemodynamic changes in long-term diuretic therapy of essential hypertension. Acta med. scand.187, 509 (1970).
Paterson, J. W., Dollery, G. T.: Effect of propranolol in mild hypertension. Lancet1966 II, 1148.
Pritchard, B. N. C., Gillam, P. M. S.: Propranolol in hypertension. Amer. J. Cardiol.18, 387 (1966).
—— —— Treatment of hypertension with propranolol. Brit. med. J.1969 I, 7.
Sannerstedt, R. Stenberg, J., Johansson, G., Werkö, L.: Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Amer. J. Cardiol. In press.
-- -- Werkö, L.: Hemodynamic studies on the antihypertensive effects of guancydine. Pharmacol. Clin. In press.
Schröder, G., Werkö, L.: Hemodynamic studies and clinical experience with nethalide, a β-adrenergic blocking agent. Amer. J. Cardiol.15, 58 (1965).
Tibblin, G., Ablad, B.: Antihypertensive therapy with alprenolol, a β-adrenergic receptor antagonist. Acta med. scand.186, 451 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Werkö, L. New treatment for hypertension. Eur J Clin Pharmacol 3, 61–62 (1971). https://doi.org/10.1007/BF00619295
Issue Date:
DOI: https://doi.org/10.1007/BF00619295